Lizinna®

  • Lizinna® is a monophasic combined oral contraceptive (COC), containing 250mcg norgestimate and 35mcg ethinylestradiol1
  • Each pack of Lizinna® contains 3 x blister strips of 21 tablets for 3 cycles of contraceptive cover2
lizinna
Please refer to the full Summary of Product Characteristics (SmPC) before prescribing.

Summary of Product Characteristics and Patient Information Leaflet
Summary of Product Characteristics:
https://www.medicines.org.uk/emc/product/9573/smpc

Patient Information Leaflet:
https://www.medicines.org.uk/emc/product/9573/pil

Additional Prescriber Resources
The full NICE Clinical Knowledge Summary for contraceptive prescribing for combined oral contraceptives, including UK Medical Eligibility Criteria may be found here.

References

  1. Morningside Healthcare Ltd. Lizinna 250 microgram /35 microgram Tablets. Summary of Product Characteristics. July 2019. Available at: https://www.medicines.org.uk/emc/product/9573/smpc (accessed June 2020);
  2. MIMS. Lizinna. Available at: https://www.mims.co.uk/drugs/contraception/combined-contraceptives/lizinna (accessed June 2020).